Brief: AnPac Bio Signs A Multi-Million Dollar Contract For Cancer Screening
19/06/2020 13:18
June 19 (Reuters) - AnPac Bio-Medical Science Co Ltd
ANPC.O :
* ANPAC BIO SIGNS A RECORD MULTI-MILLION DOLLAR CONTRACT FOR
CANCER SCREENING
* ANPAC BIO- ENTERED INTO 3-YA STRATEGIC CANCER SCREENING
COLLABORATION CONTRACT WITH BEIJING YUAN JIAN HEALTH MANAGEMENT
* ANPAC BIO- CONTRACT CONTAINS MINIMUM OF 76,000 PAID CANCER
SCREENING TESTS
* ANPAC BIO-MEDICAL SCIENCE CO LTD - VALUE OF CONTRACT IS
SLIGHTLY
OVER US$3 MILLION
Source text for Eikon: ID:nGNX6Nv897
Further company coverage: ANPC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh2
See all newsBrief: Fresh2 Group On Dec 20, Received Nasdaq Notice That It Will Be Delisted From Nasdaq Capital Market Effective At Open Of Market On Dec 24
Brief: Fresh2 Group Ltd. Announces Receipt Of Staff Delisting Determination From Nasdaq Intends To Request A Hearing
Brief: Fresh2 Group Ltd Announces Receipt Of A Delinquency Compliance Alert Notice From Nasdaq
Brief: Anpac Bio-Medical Science - In Dec 2022 And Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors
Brief: AnPac Bio Granted Continued Listing By Nasdaq Hearing Panel, Subject To Meeting $1 Bid Price Compliance Rule On Or Before Nov. 23, 2022